URGN
UroGen Pharma Ltd
41.40$
+0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of UroGen Pharma Ltd (URGN) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/20/2026 | Current report (8-K) | UroGen Pharma Ltd. (URGN): Other Events | View report ↗ |
| 08/05/2026 | Current report (8-K) | UroGen Pharma Ltd. (URGN): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.